Insider · CIK 0001773900
Joerg Neermann
Files at IMUX (IMMUNIC, INC.). First filing Jun 5, 2025, latest Jun 5, 2025.
In brief
Joerg Neermann files SEC Form 4 as director at IMUX (IMMUNIC, INC.). Since Jun 5, 2025, Joerg Neermann has reported 1 open-market buy worth $77k and 0 open-market sells worth $0, the latest filed on Jun 5, 2025.
A track record needs three past buys with six months of prices behind them; Joerg Neermann has 0, so none is measured yet.
The newest scored trade: bought $77k of IMUX on Jun 4, 2025, filed Jun 5, 2025, scored 56 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMUX: IMMUNIC, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | IMMUNIC, INC. | $77k 100,000 shares | +100% | +17% from low-60% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 5, 2026 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivative | +25,370 | $0.00 | $0 | 25,370 | Jul 7, 2026 |
| Jun 29, 2026 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivative | +25,370 | $0.00 | $0 | 25,370 | Jun 29, 2026 |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivative | +150,000 | $0.00 | $0 | 150,000 | Jun 9, 2025 |
| Jun 4, 2025 | IMUX IMMUNIC, INC. | POpen-market purchase Common Stock | +70,000 | $0.77 | $54k | 170,000 | Jun 5, 2025 |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | POpen-market purchase Common Stock | +30,000 | $0.76 | $23k | 200,000 | Jun 5, 2025 |
| Mar 4, 2024 | IMUX IMMUNIC, INC. | DDisposition to issuer Stock Optionderivative | -29,959 | - | - | 0 | Mar 6, 2024 |
| Mar 4, 2024 | IMUX IMMUNIC, INC. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Mar 6, 2024 |
| Mar 4, 2024 | IMUX IMMUNIC, INC. | DDisposition to issuer Stock Optionderivative | -10,000 | - | - | 0 | Mar 6, 2024 |
| Mar 4, 2024 | IMUX IMMUNIC, INC. | DDisposition to issuer Stock Optionderivative | -10,000 | - | - | 0 | Mar 6, 2024 |
| Mar 4, 2024 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivative | +64,959 | - | - | 64,959 | Mar 6, 2024 |
Questions about Joerg Neermann
Answered from the filings on this page, as of the latest one.
Is Joerg Neermann buying or selling?
Not in the last 12 months. Joerg Neermann's latest open-market trade on SEC Form 4 was bought $77k of IMUX on Jun 4, 2025.
How did Joerg Neermann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joerg Neermann has 0.
Where does Joerg Neermann file Form 4?
Joerg Neermann has filed Form 4 at IMUX (IMMUNIC, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.